ERS Research Seminars
Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
How can treatable traits be used in severe exacerbations?
M. Bafadhel (Oxford, United Kingdom)
Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bafadhel (Oxford, United Kingdom). How can treatable traits be used in severe exacerbations?. Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Managing COVID-19 illness: chest radiographs support defining both prognosis and follow up.
A 51-year-old man with 10-day history of cough, fever, odynodysphagie, dyspnea and fatigue
A 21-year-old male with high grade fever intermittent with chills
Related content which might interest you:
Are comorbidities related to frequent severe exacerbations of COPD?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Only severe asthma?
Source: International Congress 2019 – PG11 Severe paediatric asthma
Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma
Source: International Congress 2017 – Many faces of asthma and allergies
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Are severe and moderate exacerbations different entities?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma
Source: Eur Respir J 2003; 22: 397-398
Prevalence of non-pharmacological treatable traits in patients with asthma
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
How can we better treat infective exacerbations of COPD?
Source: Annual Congress 2012 - Prevention and treatment of infective exacerbations of COPD
Factors associated with frequent exacerbations in patients with severe asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 369s
Should patients with life-threatening severe asthma be intubated?
Source: Virtual Congress 2021 – PDW End of life care for the elderly asthmatic and COPD patients
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Treatment of severe stable COPD: the multidimensional approach of treatable traits
Source: ERJ Open Res, 6 (3) 00322-2019; 10.1183/23120541.00322-2019
Are COPD exacerbations associated with the severity of the disease?
Source: Eur Respir J 2005; 26: Suppl. 49, 300s
Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 72s
Is severe infantile bronchiolitis associated with severe childhood asthma? A whole population linkage study
Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology
Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Predicting frequent exacerbations in a severe asthma centre.
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Late Breaking Abstract - Which treatable traits matter? Prevalence of treatable traits and risk of exacerbation in a random population sample with asthma
Source: International Congress 2018 – Notable Studies in Asthma